Brief: Gentian Diagnostics Q4 EBITDA Loss NOK 1.5 Mln

Gentian Diagnostics ASA

16/02/2023 07:18

Feb 16 (Reuters) - Gentian Diagnostics ASA  GENT.OL :
    * SALES OF MNOK 27.9 IN Q4 22, UP 28% (23% ORGANIC GROWTH)
FROM
4Q21
    * EBITDA WAS MNOK -1.5 IN 4Q22

Source text for Eikon:  ID:nObiLdkK4a 
Further company coverage:  GENT.OL 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))